What are the commonly used chemotherapy regimens for endometrial cancer?

Patients with endometrial cancer usually have vaginal bleeding. It is recommended to take Chinese medicine while taking chemotherapy, which can inhibit cancer. So, do you know what the chemotherapy regimen for endometrial cancer is? How many times should endometrial cancer be treated with chemotherapy?

Usually, four to six courses of chemotherapy after surgery are enough. If the course of chemotherapy is over after four times, you can also consider seeing Chinese medicine. At this time, it will be better to consolidate the treatment for a period of time through Chinese medicine diagnosis and treatment.

The chemotherapy regimen for endometrial cancer needs to be developed to best suit the different types of endometrial cancer patients so that the most suitable chemotherapy regimen can be determined for the patient and enable the patient to achieve the desired effect.

Common chemotherapy regimens for endometrial cancer are: AP-doxorubicin + cisplatin, CAP-cyclophosphamide + doxorubicin + cisplatin, TC-paclitaxel + carboplatin, TAP-paclitaxel + doxorubicin + cisplatin. These four chemotherapy regimens have significant toxicity, so the best chemotherapy regimen remains to be explored. In comparison, paclitaxel + carboplatin combined chemotherapy is an effective and less toxic regimen for treating early or advanced recurrent endometrial cancer with medium or high risk.

Early endometrial cancer accounts for about 75% of endometrial cancer. If there are no risk factors, the prognosis is generally good and surgery can cure it. Early endometrial cancer has independent prognostic factors, such as lymph node invasion range, histological grade III, histological type, depth of myometrial invasion, cervical invasion, and patient age.

Endometrial cancer patients with risk factors have a higher postoperative recurrence rate. For patients with early endometrial cancer with combined risk factors, whether to perform postoperative adjuvant therapy and the adjuvant therapy regimen are currently hot topics. The specific chemotherapy regimen is carboplatin (AUC=5) + paclitaxel 175mg/m2, 18 days as one course of treatment, for a total of 6 courses.

Choosing the appropriate chemotherapy regimen for treatment based on the patient's own condition is the guarantee of effective treatment, which is worth noting to endometrial cancer patients who need chemotherapy.